These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 3550656)
1. Hallucinogens. Brown RT; Braden NJ Pediatr Clin North Am; 1987 Apr; 34(2):341-7. PubMed ID: 3550656 [TBL] [Abstract][Full Text] [Related]
2. The hallucinogens and the inhalants. Cohen S Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885 [TBL] [Abstract][Full Text] [Related]
3. Comparison of psilocin with psilocybin, mescaline and LSD-25. WOLBACH AB; MINER EJ; ISBELL H Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905 [No Abstract] [Full Text] [Related]
4. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION. HARTMAN AM; HOLLISTER LE Psychopharmacologia; 1963 Aug; 4():441-51. PubMed ID: 14048565 [No Abstract] [Full Text] [Related]
5. Management of hallucinogen abuse. Haddad LM Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215 [TBL] [Abstract][Full Text] [Related]
7. [Narcotics abuse in adolescents]. Leuner H Nervenarzt; 1971 Jun; 42(6):281-91. PubMed ID: 4931883 [No Abstract] [Full Text] [Related]
8. Some aspects of the current drug scene with emphasis on drugs in use by adolescents. Louria DB Pediatrics; 1968 Dec; 42(6):904-11. PubMed ID: 5726384 [No Abstract] [Full Text] [Related]
9. PATTERNS OF HALLUCINOGENIC DRUG ABUSE. LUDWIG AM; LEVINE J JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246 [No Abstract] [Full Text] [Related]
10. Deceptions in the illicit drug market. Cheek FE; Newell S; Joffe M Science; 1970 Feb; 167(3922):1276. PubMed ID: 5460848 [No Abstract] [Full Text] [Related]
11. [APROPOS OF OPTIC DISORDERS IN AUTOEXPERIMENTS WITH HALLUCINOGENS]. GROF S Cesk Psychiatr; 1964 Jun; 60():173-82. PubMed ID: 14177526 [No Abstract] [Full Text] [Related]
12. Discriminable stimuli produced by hallucinogens. Kuhn DM; White FJ; Appel JB Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285 [No Abstract] [Full Text] [Related]
13. "MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES. TOLAN EJ; LINGL FA Am J Psychiatry; 1964 Feb; 120():757-61. PubMed ID: 14117647 [No Abstract] [Full Text] [Related]
14. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS. CHARALAMPOUS KD; KINROSS-WRIGHT J Tex State J Med; 1963 Sep; 59():848-52. PubMed ID: 14054727 [No Abstract] [Full Text] [Related]
15. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'. Koerner J; Appel JB Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022 [TBL] [Abstract][Full Text] [Related]
16. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS. HOLLISTER LE; SJOBERG BM Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873 [No Abstract] [Full Text] [Related]
17. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)]. JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C Encephale; 1964; 53():520-35. PubMed ID: 14222727 [No Abstract] [Full Text] [Related]
19. [The abuse of psychodelics: a social and medical problem]. Nowak S; Herman Z Pol Tyg Lek; 1970 May; 25(19):698-701. PubMed ID: 4912910 [No Abstract] [Full Text] [Related]
20. Comparative effects of hallucinogenic drugs on behavior of the cat. Jacobs BL; Trulson ME; Stark AD; Christoph GR Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265 [No Abstract] [Full Text] [Related] [Next] [New Search]